|
Skin cell back to embryo stage
(Reuters)
Updated: 2005-08-22 13:58
WASHINGTON - U.S. researchers said on Monday they have created a new human
embryonic stem cell by fusing an embryonic stem cell to an ordinary skin cell.
They hope their method could someday provide a way to create tailor-made
medical treatments without having to start from scratch using cloning
technology.
That would mean generating the valuable cells without using a human egg, and
without creating a human embryo, which some people, including President George
W. Bush, find objectionable.
But the team, led by stem cell expert Dr. Douglas Melton, Kevin Eggan and
others at Harvard Medical School, stress in a report to be published in next
Friday's issue of the journal Science that their method is not yet perfect.
Stem cells are the body's master cells, used to continually regenerate
tissues, organs and blood. Those taken from days-old embryos are considered the
most versatile. They can produce any kind of tissue in the body.
Doctors hope to someday use embryonic stem cells as a source of perfectly
matched transplants to treat diseases such as cancer, Parkinson's and some
injuries.
But because some people object to the destruction of or experimentation on a
human embryo, U.S. law restricts the use of federal funds for this kind of
research.
It is a hot debate in Congress and several bills have been offered for
consideration when the Senate comes back next month that would either relax the
federal restrictions or tighten them even more.
Melton has complained about the restraints and, like other experts, has used
private funding to pursue stem cell work.
REPROGRAMMING CELLS
He and other stem cell experts say they only want to understand how to
re-program an ordinary cell and hope the use of human embryos would only be a
short-term and interim step to learning how to manufacture these cells.
The Harvard team say they have taken a big step in this direction.
Currently, embryonic stem cells are either taken from embryos left over from
fertility clinics, or generated using a cloning technology called nuclear
transfer. This requires taking the nucleus out of an egg cell and replacing it
with the nucleus of an adult cell, called a somatic cell, from the person to be
treated.
Done right, this reprograms the egg, which starts dividing as if it had been
fertilized by a sperm.
"On the basis of previous experiments with (mouse embryonic stem cells) we
reasoned that human embryonic stem cells might provide an alternative source of
material for the reprogramming of human somatic nuclei," the Harvard team wrote.
So they fused embryonic stem cells to human adult skin cells, and managed to
reprogram them back to an embryonic state. The new cells acted like stem cells,
forming tumors called teratomas when injected into mice -- a classic test for a
true embryonic stem cell -- and with hoped for marker genes.
The cells also appeared to be very long-lived, another test of a true
embryonic stem cell.
And when cultured in lab dishes, the cells differentiated, or matured, into
the three major basic types of cell.
"In conclusion, these findings show that human embryonic stem cells have the
capacity to reprogram adult somatic cell chromosomes after cell fusion," the
researchers wrote.
But there is "a substantial technical barrier" they warned. The newly fused
cell contains chromosomes from the original embryonic stem cell. Therefore, it
would not be a perfect genetic match to the patient.
The researchers hope if they can get around this problem, they will have
found a way to generate the valuable cells.
|
 | | | Exhibition of "bean curd man" | | |  | | | Giant panda celebrates birthday in US zoo | | |  | | | Hello Kitty celebrates 30 | | |
|
 |
|
|
|
|
Today's
Top News |
|
|
|
Top Life
News |
|
|
|
|
|
|
|
|
|
